Schedule 13G ownership disclosure

Abeona Therapeutics Inc

Common Stock, $0.01 par value · CUSIP: 00289Y206

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nantahala Capital Management, LLC

    Shares: 4,997,101.00 · Class: 9.99%

  • Wilmot B. Harkey

    Shares: 4,997,101.00 · Class: 9.99%

  • Daniel Mack

    Shares: 4,997,101.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-049535
Form type
SCHEDULE 13G/A
Filer
ABEONA THERAPEUTICS INC.
CIK
CIK 318306
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub